Skip to main content
. 2023 Jan 6;135:102991. doi: 10.1016/j.jaut.2022.102991

Table 4.

Sensitivity analysis of statistically significant associations between pre-existing conditions and development of PASC, with common symptoms of pre-existing conditions removed.

Pre-existing condition PASC/Total Adjusted OR [1] (95% CI)
Respiratory
 Asthma 86/170 1.48 (1.06–2.08)
 Bronchitis or Emphysema 3/5 2.72 (0.44–16.90)
 COPD 6/10 0.67 (0.24–1.91)
Total Disease Category 1.42 (1.02–1.98)
Gastrointestinal
 Liver Disease 5/8 2.44 (0.56–10.67)
 Ulcerative Colitis 3/5 2.31 (0.38–14.20)
 Irritable Bowel Syndrome 39/70 1.59 (0.97–2.63)
 Chronic Diarrhea 5/9 1.01 (0.25–4.16)
 Chronic Constipation 11/14 4.60 (1.23–17.18)
 Colitis 1/1 3.20 (0.63–16.1)
 Reflux 5/8 1.54 (1.01–2.34)
Total Disease Category 1.62 (1.16–2.26)
Autoimmune
 Systemic lupus erythematosus 4/5 4.52 (0.50–41.1)
 Multiple Sclerosis 2/3 2.23 (0.20–24.48)
 Rheumatoid Arthritis 11/17 2.12 (0.75–6.04)
Total Disease Category 3.42 (1.32–8.89)
Other Conditions
 Seasonal Allergies 218/474 1.39 (1.09–1.78)
 Depression/Anxiety 61/125 1.53 (1.04–2.25)